Portola Pharmaceuticals, Inc. (PTLA) financial statements (2020 and earlier)

Company profile

Business Address 270 EAST GRAND AVENUE, SUITE 22
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments429317463319444309269
Cash and cash equivalents21513918218818658118
Short-term investments214178282130258252151
Restricted cash and investments31000  
Receivables  40101
Inventory, net of allowances, customer advances and progress billings481   
Inventory481    
Contract with customer, asset410
Other undisclosed current assets221810102063
Total current assets:462353478329466315273
Noncurrent Assets
Inventory, Noncurrent5610     
Property, plant and equipment4556633
Long-term investments and receivables37 71 168350
Long-term investments37 71 168350
Intangible assets, net (including goodwill), including: 7833 
Intangible assets, net (excluding goodwill) 7     
Other undisclosed intangible assets, net (including goodwill)  833 
Prepaid expense 0     
Other noncurrent assets      0
Other undisclosed noncurrent assets19111051216 
Total noncurrent assets:1163394153710153
TOTAL ASSETS:578386572343503416326
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29312120161824
Accounts payable131391510143
Accrued liabilities 7 010 
Employee-related liabilities1611125543
Accounts payable and other accrued liabilities18
Debt1912     
Deferred rent credit 1
Deferred revenue and credits11229103
Contract with customer, liability22
Other liabilities52 0110
Other undisclosed current liabilities482149242513(1)
Total current liabilities:102698166514126
Noncurrent Liabilities
Long-term debt and lease obligation1181555450   
Long-term debt, excluding current maturities1181555450   
Liabilities, other than long-term debt816292721284
Deferred revenue and credits192519273
Contract with customer, liability44
Other liabilities412102311
Other undisclosed noncurrent liabilities22055598   
Total noncurrent liabilities:3462271428521284
Total liabilities:449296222151736929
Stockholders' equity
Stockholders' equity attributable to parent13088347191427348296
Common stock0000000
Additional paid in capital1,9461,6141,5521,1091,077771582
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)(0)0
Accumulated deficit(1,816)(1,526)(1,205)(918)(649)(423)(286)
Stockholders' equity attributable to noncontrolling interest 2323  
Total stockholders' equity:13091349193430348296
TOTAL LIABILITIES AND EQUITY:578386572343503416326

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues117402336121011
Revenue, net2336121011
Cost of revenue
(Cost of Goods and Services Sold)
(44)(18)(0)    
Gross profit:72222236121011
Operating expenses(344)(367)(295)(305) (147)(95)
Other undisclosed operating income  0    
Operating income (loss):(271)(345)(273)(270)12(138)(84)
Nonoperating income (expense)1014(1)1(3)0(2)
Investment income, nonoperating  0(1)(3)(4)(2)
Foreign currency transaction loss, before tax     (0) 
Interest and debt expense(31)(19)(12)    
Income (loss) from continuing operations before equity method investments, income taxes:(293)(351)(286)(268)9(137)(86)
Other undisclosed loss from continuing operations before income taxes    (236)  
Loss before gain (loss) on sale of properties:(293)(351)(286)(268)(227)(137)(86)
Other undisclosed net income    0  
Net loss:(293)(351)(286)(268)(227)(137)(86)
Net income (loss) attributable to noncontrolling interest20(0)(1)   
Other undisclosed net income attributable to parent      3
Net loss available to common stockholders, diluted:(291)(350)(286)(269)(227)(137)(83)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(293)(351)(286)(268)(227)(137)(86)
Other comprehensive income0      
Other undisclosed comprehensive income (loss) 0(0)0   
Comprehensive loss:(293)(350)(286)(268)(227)(137)(86)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest20(0)(1)(226)  
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    227(0)3
Comprehensive loss, net of tax, attributable to parent:(290)(350)(286)(269)(226)(137)(83)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: